Magellan - Model MAG200 - Stem Cells

Our product MAG200 has successfully completed Phase I/II of a clinical trials on the use of allogeneic (donor) off-the-shelf stem cell therapy for OA. The pivotal Phase III trial is planned to commence 2023.

Most popular related searches

stem cell

stem cell therapy

Pre-clinical research
Phase I & II for Clinical Safety and primary efficacy
Phase III for Clinical Efficacy Trial – starting end 2023

Magellan Stem cells has secured a laboratory in southeast Melbourne and will shortly commence construction of a good manufacturing practice laboratory with the aim to complete by second quarter of 2023 and to apply for accreditation of GMP lab with the TGA soon after.

Magellan - Model MAG200 - Stem Cells

Products Details